Solving lymphoma’s stem-cell problem
نویسندگان
چکیده
منابع مشابه
Malignant Lymphomas • Decision Making and Problem Solving
Follicular lymphoma (FL) is one the most frequent subtypes of lymphoma worldwide and its incidence is rapidly increasing in western countries. The vast majority of patients with follicular lymphoma present with advanced stage disease (Ann Arbor stage III or IV) at initial diagnosis, which is considered incurable by conventional therapeutic approaches. Until recently, decades of intense clinical...
متن کاملAutologous Stem Cell Transplantation for Aggressive Lymphomas
The role of high-dose therapy (HDT) followed by autologous stem cell transplantation (ASCT) in the treatment armamentarium of aggressive B- and T-cell non-Hodgkin lymphoma (NHL) is still a matter of debate. In the pre-Rituximab era, the PARMA study demonstrated the superiority of HDT/ASCT over conventional salvage chemotherapy in chemosensitive, relapsed patients. Subsequently, HDT/ASCT has bec...
متن کاملthe algorithm for solving the inverse numerical range problem
برد عددی ماتریس مربعی a را با w(a) نشان داده و به این صورت تعریف می کنیم w(a)={x8ax:x ?s1} ، که در آن s1 گوی واحد است. در سال 2009، راسل کاردن مساله برد عددی معکوس را به این صورت مطرح کرده است : برای نقطه z?w(a)، بردار x?s1 را به گونه ای می یابیم که z=x*ax، در این پایان نامه ، الگوریتمی برای حل مساله برد عددی معکوس ارانه می دهیم.
15 صفحه اولAutologous stem cell transplantation for T-cell lymphomas.
Peripheral T-cell lymphomas (PTCLs) are a rare and heterogeneous group of T-cell malignancies characterized by a very poor outcome. The optimal treatment for PTCLs remains controversial. The role of stem cell transplantation in PTCLs has been investigated; however, no randomized control studies specifically dedicated to PTCLs are currently available. Several retrospective and prospective studie...
متن کامل8.01.529 Hematopoietic Stem-Cell Transplantation for Non-Hodgkin Lymphomas
Non-Hodgkin Lymphoma (NHL) B-Cell aggressive subtype (except mantle cell) Myeloablative autologous, myeloablative allogeneic or reduced-intensity conditioning (RIC) allogeneic HSCT with curative intent may be considered medically necessary: As salvage for patients not in complete remission (CR) after first line chemotherapy induction; To achieve or consolidate a CR in chemotherapy sensitive...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2018
ISSN: 0028-0836,1476-4687
DOI: 10.1038/d41586-018-07364-3